Pediatric Hematology-Oncology Grand Rounds

Thursday, January 1, 2026, 8:00 AM - Thursday, December 31, 2026, 9:00 AM, Surgical Commons, Lowder third floor and Zoom, Birmingham, AL


The Pediatric Hematology-Oncology Grand Rounds will inform physicians and other health care professionals of advances and their scientific basis across various fields within the specialty. Since many members attending this activity are directly involved in the care of patients, when the patient and their treatment regimens, or new developments in the field are discussed and explored in this setting all feel increase comfort in caring for the patients as the rational is well known and has been discussed among peers and by experts. Competence is caring for our patient population will improve by increasing the awareness of diagnostic and therapeutic options and rational for the treatment of pediatric cancers and blood disorders. This will lead to improvements in performance as measured by treating patients on or according to cooperative group studies and ideally in patient outcomes as reported by the hospital.

1. The Pediatric Hematology-Oncology Grand Rounds will have the main goal of providing an ongoing forum about advances and their scientific basis across various fields within Hematology-Oncology. This monthly series will feature national and regional speakers and hopefully will spark communication and collaboration within scientific and clinical programs.

Children's of Alabama designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Children’s of Alabama is accredited by the Medical Association of the State of Alabama to provide continuing medical education for physicians.

AMA PRA Category 1 Credits™ (1.00 hours)

Mitigation of Relevant Financial Relationships

Children's of Alabama adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.